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Extended-release metoprolol 
succinate in patients undergoing 
non-cardiac surgery
β-blockers as short-term therapy among persons undergoing non-
cardiac surgery have been tested in multiple trials with somewhat 
conflicting results. Now, a new trial reveals the effects of extended-
release metoprolol succinate in this patient population. The trial 
randomized 8351 patients with or at risk of atherosclerotic disease 
to receive extended-release metoprolol succinate or placebo begin-
ning 2–4 hours before surgery and continuing for 30 days. Patients 
were followed for the end point of cardiovascular death, non-fatal 
myocardial infarction, and non-fatal cardiac arrest. The use of meto-
prolol reduced the primary composite end point with diminutive 
statistical significance (P=0.0399) that was largely driven by a reduc-
tion in non-fatal myocardial infarction. There were, however, more 
deaths and strokes in the metoprolol group. Although this trial does 
not specifically report on the subgroup with chronic kidney disease, 
its message is relevant to nephrologists on a higher level.
We recently learned in anemia management that an association 
is not always confirmed as a cause–effect relationship, particu-
larly in the direction in which it was expected.1 With respect to 
β-blockade, a recent retrospective study of 2126 patients undergo-
ing non-cardiac vascular surgery found that patients with a creati-
nine clearance of less than 60 ml/min receiving β-blockers lived 
longer than those not receiving β-blockers.2 This scenario repre-
sents an important opportunity for nephrologists to recognize the 
limitations of observational data and seek opportunities to conduct 
clinical trials to test whether these observational associations can 
definitively be elevated to the status of cause and effect. (Lancet 
2008; 371: 1839–1847; doi:10.1016/S0140-6736(08)60601-7)
Lynda Szczech
1N Engl J Med 2006; 355: 2085–2098. 2Kidney Int 2007; 72: 1527–1534.
Egr-2 controls the self-tolerance  
of T cells and prevents development 
of lupus-like disease
Interaction of the T-cell receptor with antigen can lead to an 
immune response, tolerance, or homeostatic proliferation, 
depending on the properties of the antigen and the context in 
which it is encountered. The outcome of a T-cell response to anti-
gen stimulation is regulated by the complex interaction of stimu-
latory and inhibitory pathways. In optimal immune responses, 
antigen and costimulatory molecules from activated antigen-pre-
senting cells induce strong mitogenic signals in naive T cells, lead-
ing to proliferation and differentiation of effector T cells. However, 
under tolerant or homeostatic conditions, such as the lack of cos-
timulatory signals or self-antigen stimulation, T cells either do not 
respond or undergo homeostatic proliferation. How self-reactive 
Platelet-derived growth  
factor-α receptor is required  
for CMV infection
Human cytomegalovirus (HCMV) infection is widespread (in 
50%–80% of seropositive individuals), but the virus can be 
an important pathogen in immunocompromised individuals. 
Despite antiviral drugs and prophylactic maneuvers. Upon 
attachment to the cell, the virus induces a potent cellular 
interferon-like response, which activates downstream growth 
factor-like receptor tyrosine kinase (RTK) and integrin signal-
ing pathways. However, the mechanisms facilitating viral entry 
and gene expression are not clearly understood. In a recent 
communication, Soroceanu et al. reported that the platelet-
derived growth factor-α receptor (PDGFR-α) is needed for 
viral entry into the cell and subsequent gene expression. They 
found that PDGFR-α was phosphorylated by both laboratory 
and clinical isolates of HCMV in various human cell types 
(Figure), resulting in activation of the phosphoinositide-3-ki-
nase signaling pathway. Cells in which PDGFR-α was geneti-
cally deleted or functionally blocked were non-permissive to 
HCMV entry, viral gene expression, or infectious virus pro-
duction. Reintroducing human PDGFRA gene into knockout 
cells restored susceptibility to viral entry and gene expres-
sion. Viral entry in cells with PDGFR-α was competitively 
inhibited by pretreatment with PDGF-AA. More interestingly, 
blockade of receptor function with a humanized PDGFR-α 
blocking antibody (IMC-3G3) or targeted inhibition of its 
kinase activity with imatinib mesylate (Gleevec) completely 
prevented HCMV viral internalization and gene expression. 
These exciting results indicate that PDGFR-α is required for 
HCMV cell entry and action, and provide new possibilities for 
effective treatments of HCMV infection. (Nature 2008; 455: 
391–395; doi:10.1038/nature07209)
Juan Oliver
Immunofluorescence of pp65 of HCMV and phospho-PDGFR-α in several 
cell types stimulated with mock, HCMV, or PDGF. Nuclei are stained with 
4,6-diamidino-2-phenylindole. HELs, human embryonic lung fibroblasts; 
HUVECs, human umbilical vein endothelial cells.
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T cells are kept functionally inactive and the molecular pathways 
controlling the different responses after T-cell receptor engage-
ment are largely unknown. Researchers recently found that early 
growth response gene 2 (Egr-2) is induced in tolerant T cells in 
response to antigen stimulation. Egr-2 is expressed in thymocytes 
and mature T cells upon T-cell receptor stimulation, but the func-
tion in vivo of Egr-2 has not been studied, as Egr-2 knockout mice 
die perinatally. In a recent study, Zhu et al. reported that Egr-2 is 
expressed in effector-phenotype T cells in the absence of obvious 
antigen stimulation in vivo. In Egr-2 conditional knockout (Egr-2 
cKO) mice, in which the gene was deleted in CD2+ lymphocytes, 
T cells did not show altered primary activation but were hyper-
proliferative in response to prolonged stimulation, leading to the 
development of a lupus-like syndrome in older mice (Figure). 
These results demonstrate that Egr-2 is a critical controller of 
the self-tolerance of T cells, and that it prevents autoimmunity 
through activation of negative regulators of cell proliferation and 
by controlling proinflammatory cytokine expression. (J Exp Med 
2008; 205: 2295–2307; doi:10.1084/jem.20080187)
Juan Oliver
Six2 defines and regulates 
multipotent, self-renewing  
nephron progenitors
Kidney development results from reciprocal interactions between 
the Wolffian duct-derived ureteric bud and the adjacent metane-
phric mesenchyme. The mesenchymal cells support branching and 
growth of the ureteric bud cells, and signaling from the ureteric bud 
is required for a cell population in the adjacent mesenchyme to epi-
thelialize, establishing the renal vesicle, the nephron precursor. The 
ureteric epithelium generates the collecting ducts, whereas other 
renal cell populations are likely generated from the mesenchymal 
cells. The homeodomain transcriptional regulator Six2 was recently 
found to be a key factor within the kidney mesenchyme; its expres-
sion was identified in a subset of metanephric mesenchyme cells 
throughout kidney development but not in the adult kidney. In 
Six2-null mice, ectopic renal vesicles form on the cortical side of the 
ureteric bud, but as nephrogenesis starts, the pool of progenitor cells 
is lost and nephrogenesis terminates after induction of only a few 
nephrons. Thus, Six2 is required to maintain a nephron progenitor 
population. In a recent article, Kobayashi et al. examined which 
cells within this population of progenitor cells give rise to nephrons, 
and how multiple nephron lineages form during the developmental 
process. The authors used genetic cell-fate analysis and determined 
the contribution of Six2+ cells to mammalian nephrogenesis. They 
found that among the mesenchymal-cell populations that surround 
the ureteric bud, the Six2-expressing cells, which lie in close proxim-
ity to the inductive ureteric epithelium (Figure), are a multipotent 
nephron progenitor population. Six2-expressing cells gave rise to all 
cell types of the main body of the nephron during all stages of neph-
rogenesis, and the cells were not found to contribute to other parts 
of the kidney. The Six2+ cell population undergoes a significant 
expansion as nephrogenesis takes place; interestingly, pulse labeling 
of Six2-expressing nephron progenitors at the onset of kidney devel-
opment suggested that the Six2-expressing cells are maintained by 
self-renewal. Clonal analysis showed that at least some Six2-express-
ing cells were multipotent, contributing to multiple domains of the 
nephron. This finding confirms old observations that individual 
nephron progenitors can generate cells from molecularly distinct 
compartments of the nephron. Furthermore, Six2 cells functioned 
autonomously to maintain a progenitor-cell status. These elegant 
experiments suggest that Six2 cell activity autonomously regulates a 
multipotent nephron progenitor population, and that Six2 ensures 
the development of a full complement of nephrons. (Cell Stem Cell 
2008; 3: 169–181; doi:10.1016/j.stem.2008.05.020) 
Qais Al-Awqati
(a) Tissue sections of kidney from Egr-2 cKO mice stained with antibodies 
against CD3 (red) and B220 (green); sections counterstained with 
4,6-diamidino-2-phenylindole (DAPI) for nuclear staining. (b) Proteinuria 
in wild-type (WT) and Egr-2 cKO mice. (c) Glomeruli of an Egr-2 cKO mouse 
and an age-matched WT mouse. (d) Immune complex deposition in 
glomeruli of Egr-2 cKO (left) but not in age-matched wild-type mice (right), 
as detected by anti-mouse Ig (red); DAPI-counterstained sections.
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Six2-eGFP transgenes are expressed in the cap mesenchyme. Whole-
mount kidneys. (a–c) Bright view. (d–f) Green fluorescent protein (GFP) 
expression. (g–i) Confocal immunofluorescence images of GFP (green), 
Six2 (red), and cytokeratin (purple). Cytokeratin is expressed in the 
ureteric tip and collecting duct. Arrows and arrowheads indicate Six2+, 
GFP+, and Six2+ GFP− cells, respectively. dpc, days postcoitus. GCE, 
eGFPCreERT2; TGC, tet-off-e GFPCre.
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